Introduction
Cells are highly sensitive to conditions that disrupt the environment of the ER or that increase demand on its machinery for synthesis, maturation, and transport of secretory cargo. Under such conditions of ER stress, cells launch the unfolded protein response (UPR) to balance client protein load with the folding capacity of the ER. Three distinct signaling pathways comprise the mammalian UPR and are initiated by the ER transmembrane sensor protein kinase RNA activated-like ER kinase (PERK), activating transcription factor 6 (ATF6), and inositol-requiring enzyme 1 (IRE1; Ron and Walter, 2007) . Activated PERK phosphorylates the  subunit of eukaryotic initiation factor 2 (eIF2-), effectively down-regulating protein synthesis (Harding et al., 2000b) . Proteolytic processing of ATF6 yields an active transcription factor (Haze et al., 1999; Ye et al., 2000) that upregulates expression of ER resident quality control proteins, including chaperones and ER-associated degradation (ERAD) components (Wu et al., 2007; Yamamoto et al., 2007; Adachi et al., 2008) . Upon activation of IRE1, its endoribonuclease activity initiates an unconventional cytosolic splicing of XBP1 mRNA, resulting in a translational frameshift that generates XBP1(S), a basic leucine zipper transcription factor (Shen et al., 2001; Yoshida et al., 2001; Calfon et al., 2002) . XBP1(S) enhances a variety of ER and secretory pathway processes by upregulating expression of genes involved in protein entry into the ER, protein folding and maturation, ERAD, and vesicular trafficking Shaffer et al., 2004) . If ER stress is not sufficiently alleviated by these adaptive mechanisms, the UPR can commit the damaged cell to death (Tabas and Ron, 2011) .
XBP1 is subject to transcriptional, posttranscriptional, and posttranslational controls (Chen and Qi, 2010; Lee et al., 2011; Wang et al., 2011; Yanagitani et al., 2011; Majumder et al., 2012) , indicating that the activity of this crucial UPR transcription factor is carefully balanced. MicroRNAs (miRNAs), 22-nt single-stranded RNAs that typically exert posttranscriptional control of gene activity (Bartel, 2009) , represent a sizeable class of regulators, which outnumbers kinases and phosphatases (Leung and Sharp, 2010) . A few ER stress-inducible miRNAs have been identified and shown to hinder translation of various secretory pathway proteins (Bartoszewski et al., 2011;  S tress in the endoplasmic reticulum (ER) triggers the unfolded protein response (UPR), a multifaceted signaling system coordinating translational control and gene transcription to promote cellular adaptation and survival. Microribonucleic acids (RNAs; miRNAs), singlestranded RNAs that typically function as posttranscriptional modulators of gene activity, have been shown to inhibit translation of certain secretory pathway proteins during the UPR. However, it remains unclear whether miRNAs regulate UPR signaling effectors directly. In this paper, we report that a star strand miRNA, miR-30c-2* (recently designated miR-30c-2-3p), is induced by the protein kinase RNA activated-like ER kinase (PERK) pathway of the UPR and governs expression of XBP1 (X-box binding protein 1), a key transcription factor that augments secretory capacity and promotes cell survival in the adaptive UPR. These data provide the first link between an miRNA and direct regulation of the ER stress response and reveal a novel molecular mechanism by which the PERK pathway, via miR-30c-2*, influences the scale of XBP1-mediated gene expression and cell fate in the UPR.
of endogenous XBP1. Overexpression of miR-30c-2* in HeLa cells attenuated induction of both XBP1 mRNA (Fig. 2 B) and XBP1(S) protein (Fig. 2 C) in response to tunicamycin (Tm), an inhibitor of N-linked glycosylation that triggers the UPR. In agreement with these data, the induction of XBP1-dependent, ER stress-responsive genes Adachi et al., 2008 ) SEC23B (Fig. 2 D) , which encodes a cargo receptor involved in vesicle trafficking, and DNAJB9 (Fig. S1 A) , which encodes the ER chaperone cofactor ERdj4, in response to Tm was severely impaired in cells overexpressing miR-30c-2*. In contrast, we observed normal induction of the XBP1-independent UPR target gene DDIT3 (encodes CCAAT enhancer-binding protein homologous protein [CHOP] ; Fig. S1 B; Lee et al., 2003) , indicating the presence of an intact UPR in this system. These data establish that miR-30c-2* has the capacity to limit induction of XBP1 mRNA, XBP1(S) protein, and XBP1-dependent target genes. XBP1(S) positively regulates XBP1 gene transcription ); hence, miR-30c-2* could regulate XBP1 expression by impeding translation of XBP1(S) and/or promoting degradation of XBP1 transcripts (Huntzinger and Izaurralde, 2011) . As a potential regulator of XBP1, we reasoned that expression of miR-30c-2* might be modulated during the UPR. We found that treatment of cells with either Tm or thapsigargin (Tg), an inhibitor of the ER Ca 2+ ATPase and a strong inducer of the UPR, up-regulates expression of miR-30c-2* (Fig. 3 A) . Using gene knockout mouse embryo fibroblasts (MEFs) and their wild-type counterparts, we then determined that ER stressinduced expression of miR-30c-2* is dependent on the PERK pathway of the UPR, whereas ATF6- and IRE1- are dispensable for this event (Fig. 3 B) .
PERK-mediated down-regulation of global protein synthesis leads, paradoxically, to increased translation of ATF4 (Harding et al., 2000a) , a factor that drives expression of a variety of targets, including the proapoptotic transcription factor CHOP, enzymes that reduce oxidative stress, and proteins that function in amino acid metabolism (Harding et al., 2003) . In addition, the PERK pathway activates NF-B, a dimer of Rel family proteins that regulates a myriad of genes involved in inflammation, stress responses, cell growth, and apoptosis (Karin et al., 2002; Li and Verma, 2002) . In its inactive state, NF-B is sequestered in the cytoplasm bound to proteins known as inhibitors of NF-B (IB; Baeuerle and Baltimore, 1988) . PERKmediated repression of protein synthesis depletes the cytosolic pool of IB, freeing NF-B to enter the nucleus and activate target genes (Jiang et al., 2003; Deng et al., 2004) . Bioinformatics analysis revealed a potential NF-B binding site (5-GGGGG-CTTTAT-3) 1.8 kb upstream of the mapped miR-30c-2* chromosomal location. This candidate NF-B binding site, exhibiting a 2-nt mismatch with the NF-B consensus sequence (5-gggRNNYYCC-3; the lowercase letters indicate the most common nucleotide in a variable position), was previously implicated as a functional NF-B enhancer element in the tumor Behrman et al., 2011) , suggesting that miRNAs play integral roles in the UPR. Therefore, we reasoned that miRNAs might participate in the exquisite regulation of XBP1. The obligate nature of miRNA biogenesis yields a pre-miRNA duplex. One strand of the duplex, the guide strand, is preferentially incorporated by an Argonaute protein into the RNA-induced silencing complex, promoting degradation or inhibiting translation of transcripts with base pair complementarity (Bartel, 2009) . In contrast, the partner strand of the duplex, miRNA*, accumulates to lower levels than the guide strand and is generally assumed to be degraded (Ambros et al., 2003; Yang et al., 2011) . However, emerging evidence indicates that miRNA* species can coaccumulate with their partner guide strand and mediate regulatory activity in various settings (Ro et al., 2007; Okamura et al., 2008; Yang et al., 2011) . Here, we report discovery of a miRNA* that regulates expression of XBP1, thereby influencing XBP1-mediated gene expression and cell fate in the UPR.
Results and discussion miR-30c-2* is a potential regulator of XBP1 expression
Using two computational algorithm programs, TargetScan (Lewis et al., 2005) and MicroCosm (Krek et al., 2005) , we searched for miRNAs with potential base pair complementarities to conserved sequences in the XBP1 mRNA 3 untranslated region (UTR). This survey predicted a target site, featuring attributes of functional miRNA, for miR-30c-2* (recently designated miR-30c-2-3p) in the XBP1 3 UTR ( Fig. 1 A, left) . First, the 7-nt sequence in the XBP1 3 UTR exhibiting Watson-Crick pairing to positions 2-8, the "seed" region (Lewis et al., 2005) , of miR-30c-2* is conserved across the three species assessed ( Fig. 1 A, right) . Second, miR-30c-2* includes a conserved 5 U ( Fig. 1 A, left) . Sequence analysis of miRNA* strand populations has revealed a strong disfavor for 5 G, a feature avoided by recognized miRNA regulatory strands (Frank et al., 2010; Yang et al., 2011) . Finally, the sequences of both miR-30c-2* and its guide strand, miR-30c (recently designated miR-30c-2-5p; Fig. 1 B) , are identical across numerous species, including Homo sapiens and Mus musculus (Fig. 1 C) . Cross-species conservations of the miRNA sequence, the seed region, and a 5 U are all key characteristics of endogenous functional miRNA (Lai, 2002; Krek et al., 2005; Lewis et al., 2005) . Notably, our bioinformatics analysis did not reveal a target site in the XBP1 3 UTR for the corresponding guide strand miR-30c.
To test the capacity of miR-30c-2* to exert regulatory activity via its putative target site in the XBP1 3 UTR, we constructed reporter vectors containing a single copy of either the wild-type target sequence or an altered seed region (mutant [MUT]; Fig. 2 A) positioned 3 of a firefly luciferase gene. Overexpression of miR-30c-2* in NIH-3T3 fibroblasts reduced the activity of the luciferase reporter containing the wild-type target sequence but not of the luciferase reporter containing the MUT target site (Fig. 2 A) . Therefore, miR-30c-2* is functionally competent and recognizes the predicted cognate XBP1 3 UTR target site in a sequence-specific manner. Next, we asked whether miR-30c-2* can alter the expression miR-30c-2* governs UPR transcription factor XBP1 • Byrd et al.
Tm (Fig. 3 C) . We then used chromatin immunoprecipitation (ChIP) to determine whether NF-B binds to the predicted motif upstream of miR-30c-2* during the UPR. The analysis revealed a greater than eightfold enrichment of NF-B at this region after 6 h of Tm treatment (Fig. 3 D) . These data (Fig. 3, B-D) suggest that NF-B, downstream of PERK, plays a critical role in upregulating expression of miR-30c-2* in the Tm-induced UPR. necrosis factor  promoter (Shakhov et al., 1990) . Additional searches for transcription factor binding sites upstream of miR30c-2* revealed no known or predicted binding sites for either ATF4 or CHOP. Therefore, we tested whether ER stress-induced expression of miR-30c-2* involves NF-B. Overexpression of a constitutively active, dominant-negative IB- MUT (Brockman et al., 1995) attenuated induction of miR-30c-2* in response to peaked at 6 h of Tm treatment (Fig. 4 A) . Interestingly, miR30c-2* was moderately induced as early as 2 h of Tm treatment and was maximal around 6 h (Fig. 4 A) . A similar expression profile was observed in Tm-treated NIH-3T3 cells (Fig. S2) . The concomitant up-regulation of miR-30c-2* and XBP1 mRNA suggested that miR-30c-2* might influence XBP1 expression as the UPR proceeds. If so, we reasoned that inhibiting miR-30c-2* miR-30c-2* regulates XBP1 expression and the magnitude of XBP1-mediated gene transcription
We next sought to determine whether endogenous miR-30c-2* indeed targets XBP1 mRNA. We treated HeLa cells with Tm for 2-18 h and assessed the kinetics of induction for both miR-30c-2* and XBP1. As expected, XBP1 was induced early (2 h) and 
miR-30c-2* influences cell fate under conditions of ER stress
Expression of XBP1(S) and its downstream target genes is considered to be proadaptive in the UPR. Therefore, to further investigate the impact of endogenous miR-30c-2* on the overall cellular response to ER stress, we assessed the fate of HeLa cells expressing either the anti-miR-30c-2* or the inhibitor control after an extended period of UPR activation. At 0, 24, and 30 h of Tm treatment, cells were stained with 7-aminoactinomycin D (7-AAD), a fluorescent DNA intercalator dye that penetrates the compromised membranes of late-stage apoptotic or necrotic cells, and analyzed by flow cytometry. Indeed, the percentage of cells scoring as 7-AAD permeable was attenuated by anti-miR-30c-2* at all intervals tested (Fig. 5, A and B, 7-AAD Pos). To determine whether this anti-miR-30c-2* effect was in fact XBP1 dependent, we performed similar experiments in wild-type and XBP1-deficient MEFs. accumulation during the UPR would result in increased levels of XBP1 mRNA and XBP1(S) protein. To test this hypothesis, we stably expressed an miRNA inhibitor specific for miR-30c-2* in HeLa cells. In cells expressing anti-miR-30c-2*, the accumulation of miR-30c-2* in response to Tm was ablated at peak induction times (4 and 6 h; Fig. 4 B) . Conversely, when treated with Tm, cells expressing anti-miR-30c-2* exhibited greater induction of XBP1 mRNA (Fig. 4 C) , XBP1(S) protein (Fig. 4 D) and XBP1-dependent, ER stress-responsive genes Adachi et al., 2008 ) SEC23B (Fig. 4 E) , DNAJB9, SRP54A, which encodes a subunit of the signal recognition particle, and EDEM1, which encodes an ERAD component (Fig. S3, A-C) . Again, we observed normal induction of the XBP1-independent UPR target gene DDIT3 (Fig. S3 D) . These findings demonstrate that endogenous miR-30c-2* regulates expression of XBP1 during the UPR and, in turn, modulates the magnitude of XBP1(S)-mediated gene transcription. Recent studies have unveiled ER stress-inducible miRNAs that negatively regulate translation of certain secretory pathway proteins (Bartoszewski et al., 2011; Behrman et al., 2011) , affording cells another means of balancing protein load with ER capacity. In contrast, our finding that ER stress-inducible miR-30c-2* As expected, XBP1-deficient MEFs exhibited heightened sensitivity to Tm-induced toxicity as compared with wild-type MEFs (Fig. 5 C) . Importantly, expression of anti-miR-30c-2* protected wild-type, but not XBP1-deficient, MEFs against Tm-induced death (Fig. 5, C and D) . Note that anti-miR-30c-2* provided measurable improvement in the viability of untreated cells (0 h), consistent with basal UPR signaling and XBP1(S) expression under these conditions (Fig. 4 D, 
top). (C and D) XBP1
WT (wild-type [WT] ) and XBP1 / (knockout [KO]) MEFs transiently expressing either anti-miR-30c-2* or a control scrambled inhibitor were left untreated or treated with Tm for the indicated intervals and analyzed as in A. (C) Histograms discriminating viable (7-AAD negative) from dead (7-AAD positive) cells. (D) Quantitative analysis of 7-AAD-positive cells during Tm-induced ER stress. (E) Model for miR-30c-2* as a regulatory interface between the PERK and IRE1-XBP1 pathways in the UPR, regulating XBP1 expression, the strength of XBP1-mediated gene transcription, and cellular adaptation to ER stress. Data are means ± SD. *, P < 0.05. P, phospho. using two algorithm-based software programs, TargetScan (Whitehead Institute for Biomedical Research) and MicroCosm (European Bioinformatics Institute). Potential transcription factor binding sites upstream of the miR-30c-2* chromosomal location were identified using the NSITE program (Softberry) and the University of California, Santa Cruz Genome browser.
Reporter and expression vectors
The pMIR-XBP1
WT605-625 and pMIR-XBP1 Mut luciferase reporter vectors were constructed using oligonucleotides (40 base pairs) containing a single copy of either the wild-type or MUT putative miR-30c-2* target sequence present in the human XBP1 3 UTR (Integrated DNA Technologies). The MUT fragment includes target-abolishing substitutions in nucleotides 1 (A to G), 3 (C to T), and 5 (T to G) of the miR-30c-2* seed region. Both the wild-type and MUT fragment contained a BlpI site used in screening transformants. Fragments were ligated into the SpeI-HindIII sites of the pMIR-REPORT vector (Applied Biosystems), with firefly luciferase as the primary reporter gene. The pCMV-Renilla luciferase vector (Promega) provides constitutive expression of Renilla luciferase. The pCMV-miR-30c-2 and pCMV-miR-empty vector (OriGene) contain a cassette encoding GFP. pCMV-miR-30c-2 provides constitutive expression of both miR-30c and miR-30c-2*. The miArrest vectors (GeneCopoeia) pEZX-AM02-anti-miR-30c-2* and pEZX-AM02 inhibitor control contain cassettes encoding puromycin resistance and mCherry. The pEZX-AM02-anti-miR-30c-2* vector provides constitutive expression of an miR-30c-2*-specific inhibitor, and the pEZX-AM02 inhibitor control yields a scrambled, nonspecific anti-miRNA. The posttranscriptional processing of the anti-miRNA expressed from miArrest miRNA inhibitor vectors yields a structure that hybridizes with two molecules of the target miRNA, thereby trapping the miRNA and preventing it from exerting regulatory activity. The pCDNA3.1-IB-N vector, provided by W. Lin (University of South Alabama, Mobile, AL), encodes a truncated IB- lacking the amino-terminal 36 amino acids required for signal-induced degradation (Brockman et al., 1995) .
RNA isolation and quantitative real-time RT-PCR
RNAs were extracted from cells using either the miRNeasy Mini Kit for miRNA analysis or the RNeasy Plus Mini Kit (QIAGEN), and 300 ng total RNA was reverse transcribed using an RT-PCR system (miRcury LNA Universal RT microRNA PCR; Exiqon) for miRNA analysis and the reverse transcription system (ImProm-II; Promega) for mRNA analysis. Resulting cDNA from miRNA and mRNA were diluted 1:80 and 1:40, respectively. Real-time PCR was performed using a thermocycler (C1000; Bio-Rad Laboratories) with an optic module real-time detection system (CFX96; Bio-Rad Laboratories). Reactions were performed in triplicate using the SYBR green supermix (IQ; Bio-Rad Laboratories). miR-30c-2* was amplified using primers (LNA; Exiqon). Forward and reverse primers used are as follows: 5-TAGAAAGAAAGCCCGGATGAGCGA-3 and 5-GTGTC-CATTCCCAAGCGTGTTCTT-3 (mouse XBP1); 5-AAGGCTCGAATGAGT-GAGCTGGAA-3 and 5-TCCTGGTTCTCAACTACAAGGCCA-3 (human XBP1); 5-AGTCATTGCCTTTCTCCTTCGGGA-3 and 5-AAGCAGGGTCA-AGAGTGGTGAAGA-3 (human DDIT3); 5-AGCAGCAGCATTCTAGCT-GACAGA-3 and 5-GCCTGCAGAAGGTGCTTGAAGTTT-3 (human SEC23B); 5-CCCGCCTCACATTGAAATCC-3 and 5-GCGTATGTATCA-GTCTCAGTGG-3 (mouse 2M); 5-AGATGAGTATGCCTGCCGTGT-GAA-3 and 5-TGCTGCTTACATGTCTCGATCCCA-3 (human 2M); 5-AAGGGAGTGTGTGCGAGTTGTCTA-3 and 5-AATTCGTCGAGA-TCGTGCACCCTT-3 (human DNAJB9); 5-TGGACACCGACTAAGG-GAAAGCAA-3 and 5-TGGTCAAACGCTCCTGCTCTGAAT-3 (human SRP54A); and 5-TCTTAGCTCTGCAGCCACCGTAAA-3 and 5-TGGA-ACCTCCATACACTGGTCCAT-3 (human EDEM1). miRNA and transcript levels were normalized to 2-microglobulin mRNA levels (CT), and the normalized data were used to determine changes in gene expression ( 2 CT ). To analyze the effect of Tm treatment on target gene expression, untreated samples were set as a calibrator (control) and compared with their respective treated samples.
Luciferase reporter assays NIH-3T3 cells were transfected with pCMV-Renilla luciferase plus either pMIR-XBP1 , pMIR-XBP1 Mut , or pMIR-REPORT in combination with either pCMV-miR-30c-2 or pCMV-empty vector. At 24 h after transfection, cell lysates were prepared and assayed for both Renilla and firefly luciferase activity using a reporter assay kit (Dual-Luciferase Reporter Assay; Promega). Firefly luciferase activity was normalized to Renilla luciferase activity. Assays were performed in triplicate for a minimum of three independent experiments.
regulates expression of XBP1 is the first discovery of a miRNA that directly modulates a UPR effector. Moreover, our data reveal a novel regulatory interface between the PERK and IRE1-XBP1 pathways that involves NF-B and miR-30c-2* (Fig. 5 E) . It seems counterintuitive that miR-30c-2* exists to compromise cellular stress tolerance by extinguishing XBP1. Rather, we reason that overzealous expression of XBP1(S) might be deleterious depending on the nature, intensity, and duration of physiological conditions that increase demands on the ER. By buffering the level of XBP1(S), miR-30c-2* could contribute to the delicate balance between pro-and maladaptive outcomes in the UPR. Interestingly, a recent study revealed that XBP1(S) mRNA is stabilized early in the UPR and then becomes increasingly labile (Majumder et al., 2012) . In light of our data, it is intriguing to speculate that the accumulation of miR-30c-2* accelerates the turnover of XBP1(S) mRNA as the UPR progresses.
In addition to its link to the PERK pathway, NF-B can be activated downstream of many signaling molecules, including IRE1 (Kaneko et al., 2003; Hu et al., 2006) , Toll-like receptors (Kawai and Akira, 2010) , and cytokine receptors (Li and Verma, 2002) . This raises the interesting possibility that certain stimuli not obviously associated with ER stress, such as cytokines that induce NF-B, might influence XBP1 via miR-30c-2*. We hypothesize that the relative contribution of miR-30c-2* to the "fine tuning" of XBP1 activity may vary in distinct tissue-, developmental-, and stress-specific settings in which the entire UPR or individual UPR pathways are engaged. It will be particularly interesting to investigate the degree to which miR-30c-2* influences gene expression, cell function, and cell fate in normal as well as pathophysiologic processes that involve XBP1, such as plasma cell differentiation , macrophage activation by Toll-like receptor signaling (Martinon et al., 2010) , and tumor cell survival (Romero-Ramirez et al., 2004) . Finally, our data add miR-30c-2* to a small but growing list of mammalian miRNA* species with defined regulatory activities (Yang et al., 2011) , underscoring that miRNA* strands play critical roles in gene regulation.
Materials and methods
Cell culture and transfections NIH-3T3 fibroblasts, MEFs, and HeLa cells were cultured as previously described (Bommiasamy et al., 2009) Bioinformatic sequence analysis miRNA sequences were retrieved from the miRBase sequence database. Prediction of miRNA target sites in the XBP1 3 UTR was conducted Statistical analysis Statistical differences between groups were assessed using the Student's t test. A 95% confidence interval was considered statistically significant. For each dataset, n ≥ 3 and P < 0.05; error bars represent means ± SD.
Online supplemental material Fig. S1 depicts analysis of DNAJB9 and DDIT3 expression in Tm-treated HeLa cells overexpressing miR-30c-2*. Fig. S2 reports the kinetics of induction of miR-30c-2* and Xbp1 in Tm-treated NIH-3T3 cells. Fig. S3 depicts analysis of DNAJB9, SRP54A, EDEM1, and DDIT3 expression in Tm-treated HeLa cells overexpressing anti-miR-30c-2*. Online supplemental material is available at http://www.jcb.org/cgi/content/full/jcb.201201077/DC1.
